Humphries William D.
SEC CIK 1674278 · EDGAR
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| ACRS | Aclaris Therapeutics, Inc. | Dir | 45.1K | — | — | 5 | 2022-06-03 | 2026-06-05 |
Most active insiders at ACRS, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Leonard Braden Michael | 10% | — | $1.36M |
| 2 | Kolbeck Roland Wilhelm | CSO | — | — |
| 3 | Hall Jesse Wayne | Chief Medical Off | — | — |
| 4 | Davis Hugh M. | Pres, COO, Dir | — | — |
| 5 | Balthaser Kevin | CFO | — | — |
| 6 | Loerop James | Chief Business Off | — | — |
| 7 | Humphries William D. | Dir | — | — |
| 8 | Molineaux Christopher P. | Dir | — | — |
| 9 | Walker Neal | CEO, Dir | — | — |
| 10 | Mehra Anand | Dir | — | — |
Transactions 5
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2026-06-08 16:15 | 2026-06-05 | ACRS | Aclaris Therapeutics, Inc. | Humphries William D. | Dir | M - OptEx | — | +11.6K | 45.1K | +35% | — |
| D | 2025-06-09 | 2025-06-06 | ACRS | Aclaris Therapeutics, Inc. | Humphries William D. | Dir | M - OptEx | — | +4,793 | 33.5K | +17% | — |
| D | 2024-06-04 | 2024-06-01 | ACRS | Aclaris Therapeutics, Inc. | Humphries William D. | Dir | M - OptEx | — | +4,660 | 28.7K | +19% | — |
| D | 2023-06-05 | 2023-06-02 | ACRS | Aclaris Therapeutics, Inc. | Humphries William D. | Dir | M - OptEx | — | +4,507 | 24.1K | +23% | — |
| D | 2022-06-06 | 2022-06-03 | ACRS | Aclaris Therapeutics, Inc. | Humphries William D. | Dir | M - OptEx | — | +3,356 | 19.6K | +21% | — |
Purchase Sale Sale after option exercise All abbreviations